Silji Abraham is SVP, Chief Technology Officer of WEST PHARMACEUTICAL SERVICES INC. Currently has a direct ownership of 3,138 shares of WST, which is worth approximately $993,177. The most recent transaction as insider was on Oct 29, 2024, when has been sold 180 shares (Common Stock) at a price of $318.41 per share, resulting in proceeds of $57,313. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.14K
9.72% 3M change
25.45% 12M change
Total Value Held $993,177

Silji Abraham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 29 2024
SELL
Payment of exercise price or tax liability
$57,313 $318.41 p/Share
180 Reduced 5.42%
3,138 Common Stock
Oct 29 2024
BUY
Exercise of conversion of derivative security
-
458 Added 12.13%
3,318 Common Stock
Jun 12 2024
SELL
Open market or private sale
$595,404 $330.78 p/Share
1,800 Reduced 38.63%
2,860 Common Stock
Feb 23 2024
SELL
Open market or private sale
$2,559,380 $365.0 p/Share
7,012 Reduced 60.08%
4,660 Common Stock
Feb 23 2024
BUY
Exercise of conversion of derivative security
$1,214,618 $173.22 p/Share
7,012 Added 37.53%
11,672 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
646 Added 12.17%
4,660 Common Stock
Aug 08 2023
SELL
Open market or private sale
$3,243,028 $397.43 p/Share
8,160 Reduced 65.97%
4,209 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
$836,481 $102.51 p/Share
8,160 Added 39.75%
12,369 Common Stock
May 01 2023
SELL
Open market or private sale
$2,934,117 $365.85 p/Share
8,020 Reduced 65.58%
4,209 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$691,644 $86.24 p/Share
8,020 Added 39.61%
12,229 Common Stock
Mar 09 2023
SELL
Open market or private sale
$483,855 $322.57 p/Share
1,500 Reduced 26.27%
4,209 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
$74,477 $318.28 p/Share
234 Added 3.94%
5,709 Common Stock
Feb 21 2023
BUY
Grant, award, or other acquisition
$697,390 $306.68 p/Share
2,274 Added 29.35%
5,475 Common Stock
Aug 01 2022
SELL
Open market or private sale
$1,848,280 $343.93 p/Share
5,374 Reduced 62.67%
3,201 Common Stock
Feb 22 2022
BUY
Grant, award, or other acquisition
$922,087 $369.13 p/Share
2,498 Added 22.56%
8,575 Common Stock
May 10 2021
SELL
Open market or private sale
$727,285 $335.0 p/Share
2,171 Reduced 26.32%
6,077 Common Stock
Feb 26 2021
SELL
Payment of exercise price or tax liability
$190,000 $280.65 p/Share
677 Reduced 7.59%
8,248 Common Stock
Feb 22 2021
BUY
Grant, award, or other acquisition
$702,619 $272.65 p/Share
2,577 Added 22.4%
8,925 Common Stock
Oct 29 2020
BUY
Grant, award, or other acquisition
-
454 Added 6.67%
6,348 Common Stock
SA

Silji Abraham

SVP, Chief Technology Officer
Exton,

Track Institutional and Insider Activities on WST

Follow WEST PHARMACEUTICAL SERVICES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Track Activities on WST